Insider · CIK 0001394208
Christopher W Krueger
Files at VTYX (Ventyx Biosciences, Inc.). First filing Dec 21, 2023, latest Apr 3, 2024.
In brief
Christopher W Krueger files SEC Form 4 as officer at VTYX (Ventyx Biosciences, Inc.). Since Dec 21, 2023, Christopher W Krueger has reported 0 open-market buys worth $0 and 2 open-market sells worth $20k, the latest filed on Apr 3, 2024.
A track record needs three past buys with six months of prices behind them; Christopher W Krueger has 0, so none is measured yet.
The newest scored trade: sold $8,921 of VTYX on Apr 2, 2024, filed Apr 3, 2024, scored 30 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Ventyx Biosciences, Inc. | $8,921 1,651 shares | -1% | - | |
| 30Weak | Ventyx Biosciences, Inc. | $11k 5,293 shares | -2% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 2, 2024 | VTYX Ventyx Biosciences, Inc. | 1,651 0.00% of outstanding | $8,921 | Apr 2, 2024 | none |
| Dec 20, 2023 | VTYX Ventyx Biosciences, Inc. | 5,293 0.01% of outstanding | $11k | Dec 20, 2023 | $450k |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | VTYX Ventyx Biosciences, Inc. | SOpen-market sale Common Stock | -1,651 | $5.40 | $8,921 | 284,999 | Apr 3, 2024 |
| Mar 28, 2024 | VTYX Ventyx Biosciences, Inc. | MOption exercise Common Stock | +4,531 | $0.00 | $0 | 286,650 | Mar 29, 2024 |
| Mar 28, 2024 | VTYX Ventyx Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,531 | $0.00 | $0 | 13,594 | Mar 29, 2024 |
| Jan 2, 2024 | VTYX Ventyx Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Jan 3, 2024 |
| Dec 20, 2023 | VTYX Ventyx Biosciences, Inc. | SOpen-market sale Common Stock | -5,293 | $2.12 | $11k | 282,119 | Dec 21, 2023 |
| Dec 17, 2023 | VTYX Ventyx Biosciences, Inc. | MOption exercise Common Stock | +10,479 | $0.00 | $0 | 287,412 | Dec 19, 2023 |
| Dec 17, 2023 | VTYX Ventyx Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -10,479 | $0.00 | $0 | 20,958 | Dec 19, 2023 |
| Dec 18, 2023 | VTYX Ventyx Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +181,250 | $0.00 | $0 | 181,250 | Dec 19, 2023 |
Questions about Christopher W Krueger
Answered from the filings on this page, as of the latest one.
Is Christopher W Krueger buying or selling?
Not in the last 12 months. Christopher W Krueger's latest open-market trade on SEC Form 4 was sold $8,921 of VTYX on Apr 2, 2024.
How did Christopher W Krueger's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher W Krueger has 0.
Where does Christopher W Krueger file Form 4?
Christopher W Krueger has filed Form 4 at VTYX (Ventyx Biosciences, Inc.) as CHIEF BUSINESS OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.